Inherited Myopathies and Muscular Dystrophies

ABSTRACT

The inherited myopathies and muscular dystrophies are a diverse group of muscle diseases presenting with common complaints and physical signs: weakness, motor delay, and respiratory and bulbar dysfunction. The myopathies are caused by genetic defects in the contractile apparatus of muscle, and defined by distinctive histochemical or ultrastructural changes on muscle biopsy. The muscular dystrophies, in contrast, are diseases of muscle membrane or supporting proteins, which are generally characterized by pathological evidence of ongoing muscle degeneration and regeneration. Diagnosis of these disorders is contingent on a targeted history and examination, biochemical and neurophysiological assessment, muscle biopsy, and genetic testing. Treatment is focused on symptomatic management and rehabilitation, and monitoring for disease complications.

KEYWORDS

Myopathy - muscular dystrophy - pediatric

REFERENCES

• 1 Ryan M M, North K N. Congenital myopathies. In: Noseworthy J Neurological Therapeutics: Principles and Practice. Rochester, NY; Martin Dunitz 2006: 2607-2618
• 2 Yates J R, Emery A E. A population study of adult onset limb-girdle muscular dystrophy.  J Med Genet. 1985;  22 250-257
• 3 Wallgren-Pettersson C, Beggs A H, Laing N G. 51st ENMC International Workshop: Nemaline Myopathy. 13-15 June 1997, Naarden, The Netherlands.  Neuromuscul Disord. 1998;  8 53-56
• 4 Clarke N F, North K N. Congenital fiber type disproportion: 30 years on.  J Neuropathol Exp Neurol. 2003;  62 977-989
• 5 Emery A E. Population frequencies of inherited neuromuscular diseases: a world survey.  Neuromuscul Disord. 1991;  1 19-29
• 6 Mostacciuolo M L, Miorin M, Martinello F et al.. Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy.  Hum Genet. 1996;  97 277-279
• 7 Emery A EH. Duchenne Muscular Dystrophy. 2nd ed. New York; Oxford University Press 1993
• 8 Bushby K M, Thambyaya M, Gardner-Medwin D. Prevalence and incidence of Becker muscular dystrophy.  Lancet. 1991;  337 1022-1024
• 9 Harper P S. Myotonic Dystrophy. 3rd ed. London; WB Saunders Company 2001
• 10 Padberg G. Facioscapulohumeral Disease. Leiden, The Netherlands; International Graphics, University of Leiden 1982
• 11 Urtasun M, Saenz A, Roudaut C et al.. Limb-girdle muscular dystrophy in Guipúzcoa (Basque country, Spain).  Brain. 1998;  121 1735-1747
• 12 Victor M, Hayes R, Adams R D. Oculopharyngeal muscular dystrophy: familial disease of late life characterized by dysphagia and progressive ptosis of the eyelids.  N Engl J Med. 1962;  267 1267-1272
• 13 Shy G M, Magee K R. A new congenital non-progressive myopathy.  Brain. 1956;  79 610-621
• 14 Dubowitz V. The “new” myopathies.  Neuropediatrics. 1969;  1 137-148
• 15 Ryan M M, Schnell C, Strickland C D et al.. Nemaline myopathy: a clinical study of 143 cases.  Ann Neurol. 2001;  50 312-320
• 16 Quinlivan R M, Muller C R, Davis M et al.. Central core disease: clinical, pathological, and genetic features.  Arch Dis Child. 2003;  88 1051-1055
• 17 McEntagart M, Parsons G, Buj-Bello A et al.. Genotype-phenotype correlations in X-linked myotubular myopathy.  Neuromuscul Disord. 2002;  12 939-946
• 18 Mastaglia F L, Lamont P J, Laing N G. Distal myopathies.  Curr Opin Neurol. 2005;  18 504-510
• 19 Muntoni F, Voit T C. The congenital muscular dystrophies in 2004: a century of exciting progress.  Neuromuscul Disord. 2004;  14 635-649
• 20 Quijano-Roy S, Renault F, Romero N et al.. EMG and nerve conduction studies in children with congenital muscular dystrophy.  Muscle Nerve. 2004;  29 292-299
• 21 Jones K, North K. The congenital muscular dystrophies. In: Jones HR, De Vivo DC, Darras BT Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach. Philadelphia; Butterworth Heinemann 2003: 633-634
• 22 Darras B T. Muscular dystrophies.  Continuum. 2006;  12 33-75
• 23 Wicksell R K, Kihlgren M, Melin L, Eeg-Olofsson O. Specific cognitive deficits are common in children with Duchenne muscular dystrophy.  Dev Med Child Neurol. 2004;  46 154-159
• 24 Kirchmann C, Kececioglu D, Korinthenberg R, Dittrich S. Echocardiographic and electrocardiographic findings of cardiomyopathy in Duchenne and Becker-Kiener muscular dystrophies.  Pediatr Cardiol. 2005;  26 66-72
• 25 Bushby K M, Gardner-Medwin D. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy: I. Natural history.  J Neurol. 1993;  240 98-104
• 26 Gedeon A K, Wilson M J, Colley A C, Sillence D O, Mulley J C. X linked fatal infantile cardiomyopathy maps to Xq28 and is possibly allelic to Barth syndrome.  J Med Genet. 1995;  32 383-388
• 27 Sunohara N, Arahata K, Hoffman E P et al.. Quadriceps myopathy: forme fruste of Becker muscular dystrophy.  Ann Neurol. 1990;  28 634-639
• 28 Gospe S M, Lazaro R P, Lava N S et al.. Familial X-linked myalgia and cramps: a nonprogressive myopathy associated with a deletion in the dystrophin gene.  Neurology. 1989;  39 1277-1280
• 29 Hoogerwaard E M, van der Wouw P A, Wilde A A et al.. Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy.  Neuromuscul Disord. 1999;  9 347-351
• 30 Hoffman E P, Arahata K, Minetti C, Bonilla E, Rowland L P. Dystrophinopathy in isolated cases of myopathy in females.  Neurology. 1992;  42 967-975
• 31 Darras B T. Molecular genetics of Duchenne and Becker muscular dystrophy.  J Pediatr. 1990;  117 1-15
• 32 Hoffman E P, Kunkel L M. Dystrophin abnormalities in Duchenne/Becker muscular dystrophy.  Neuron. 1989;  2 1019-1029
• 33 Mendell J R, Moxley R T, Griggs R C et al.. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy.  N Engl J Med. 1989;  320 1592-1597
• 34 Manzur A Y, Kuntzer T, Pike M, Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.  Cochrane Database Syst Rev. 2004;  (2) CD003725
• 35 Moxley III R T, Ashwal S, Pandya S et al.. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.  Neurology. 2005;  64 13-20
• 36 Finsterer J, Stollberger C. The heart in human dystrophinopathies.  Cardiology. 2003;  99 1-19
• 37 Nowak K J, Davies K E. Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment.  EMBO Rep. 2004;  5 872-876
• 38 Griggs R C, Davis R J, Anderson D C, Dove J T. Cardiac conduction in myotonic dystrophy.  Am J Med. 1975;  59 37-42
• 39 Brook J D, McCurrach M E, Harley H G et al.. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member.  Cell. 1992;  68 799-808
• 40 English K M, Gibbs J L. Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders.  Dev Med Child Neurol. 2006;  48 231-235
• 41 van Engelen B G, Brunner H G. Gastrointestinal dysfunction in myotonic dystrophy. In: Harper PS, van Engelen B, Eymard B, Wilcox DE Myotonic Dystrophy: Present Management, Future Therapy. New York; Oxford University Press 2004
• 42 Ricker K, Koch M C, Lehmann-Horn F et al.. Proximal myotonic myopathy: clinical features of a multisystem disorder similar to myotonic dystrophy.  Arch Neurol. 1995;  52 25-31
• 43 Rowland L P, Fetell M, Olarte M et al.. Emery-Dreifuss muscular dystrophy.  Ann Neurol. 1979;  5 111-117
• 44 Bione S, Maestrini E, Rivella S et al.. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy.  Nat Genet. 1994;  8 323-327
• 45 Bonne G, Di Barletta M R, Varnous S et al.. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy.  Nat Genet. 1999;  21 285-288
• 46 Raffaele Di Barletta M, Ricci E, Galluzzi G et al.. Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy.  Am J Hum Genet. 2000;  66 1407-1412
• 47 Tawil R, Figlewicz D A, Griggs R C et al.. Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. FSH Consortium.  Ann Neurol. 1998;  43 279-282
• 48 Ketenjian A Y. Scapulocostal stabilization for scapular winging in facioscapulohumeral muscular dystrophy.  J Bone Joint Surg Am. 1978;  60 476-480
• 49 Diab M, Darras B T, Shapiro F. Scapulothoracic fusion for facioscapulohumeral muscular dystrophy.  J Bone Joint Surg Am. 2005;  87 2267-2275
• 50 Bushby K M. Diagnostic criteria for the limb-girdle muscular dystrophies: report of the ENMC consortium on limb-girdle dystrophies.  Neuromuscul Disord. 1995;  5 71-74
• 51 Brais B, Bouchard J P, Xie Y G et al.. Short GCG expansions in the PABP2 gene cause oculo-pharyngeal muscular dystrophy.  Nat Genet. 1998;  18 164-167
• 52 Shapiro F, Specht L. The diagnosis and orthopaedic treatment of childhood spinal muscular atrophy, peripheral neuropathy, Friedreich ataxia and arthrogryposis.  J Bone Joint Surg Am. 1993;  75 1699-1714
• 53 Hsu J D. The development of current approaches to the management of spinal deformity for patients with neuromuscular disease.  Semin Neurol. 1995;  15 24-28
• 54 Wazeka A N, DiMaio M F, Boachie-Adjei O. Outcome of pediatric patients with severe restrictive lung disease following reconstructive spine surgery.  Spine. 2004;  29 528-534
• 55 Bach J R, Niranjan V, Weaver B. Spinal muscular atrophy type 1: a noninvasive respiratory management approach.  Chest. 2000;  117 1100-1105
• 56 Mellies U, Ragette R, Schwake C et al.. Sleep-disordered breathing and respiratory failure in acid maltase deficiency.  Neurology. 2001;  57 1290-1295
• 57 Young H K, Lowe A, Fitzgerald D A et al.. Non-invasive ventilation in children with neuromuscular disease: a clinical and quality of life outcome study.  Neurology. 2007;  68 198-201
• 58 McCarthy T V, Quane K A, Lynch P J. Ryanodine receptor mutations in malignant hyperthermia and central core disease.  Hum Mutat. 2000;  15 410-417
• 59 Ryan M M, Ilkovski B, Strickland C D et al.. Clinical course correlates poorly with muscle pathology in nemaline myopathy.  Neurology. 2003;  60 665-673
• 60 Brei T J. Management of drooling.  Semin Pediatr Neurol. 2003;  10 265-270
• 61 Muntoni F. Cardiomyopathy in muscular dystrophies.  Curr Opin Neurol. 2003;  16 577-583
• 62 Lewis W R, Yadlapalli S. Management of cardiac complications in neuromuscular disease.  Phys Med Rehabil Clin N Am. 1998;  9 145-166
• 63 Tawil R. Outlook for therapy in the muscular dystrophies.  Semin Neurol. 1999;  19 81-86